Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3861-3873

  Duan, Ying Liang ^a   Ye, Han Qing ^a   Zavala, Anamaria G ^b   Yang, Cui Qing ^a   Miao, Ling Feng ^a   Fu, Bi Shi ^a   Seo Keun Seok, K S ^b,d   Davrinche, Christian ^c   Luo, Min Hua ^a   Fortunato, Elizabeth A ^b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF IDAHO   (United States)

^c Université Paul Sabatier   (France)

^d Mississippi State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IE1 GENE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRIDAE; CELL LINE, TUMOR; CYTOMEGALOVIRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HUMANS; NEUROGLIA; VIRUS LATENCY;

EID: 84895444027     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01166-13     Document Type: Article

References (86)

1. Luo MH, Fortunato EA. 2007. Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J. Virol. 81:10424-10436. http://dx.doi.org/10.1128/JVI.00866-07.
2. Bale JF, Jr. 1984. Human cytomegalovirus infection and disorders of the nervous system. Arch. Neurol. 41:310-320. http://dx.doi.org/10.1001 /archneur.1984.04050150092023.
3. Becroft DM. 1981. Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect. Pediatr. Pathol. 6:203-241.
4. Grosse SD, Ross DS, Dollard SC. 2008. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J. Clin. Virol. 41:57-62. http://dx.doi.org/10.1016/j.jcv .2007.09.004.
5. Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR. 2011. Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J. Neurovirol. 17:201-211. http://dx.doi .org/10.1007/s13365-011-0024-7.
6. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. 1986. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
7. Conboy TJ, Pass RF, Stagno S, Britt WJ, Alford CA, McFarland CE, Boll TJ. 1986. Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics 77:801-806.
8. Nassetta L, Kimberlin D, Whitley R. 2009. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J. Antimicrob. Chemother. 63:862-867. http://dx.doi.org/10.1093/jac /dkp083.
9. Pass RF, Stagno S, Myers GJ, Alford CA. 1980. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 66:758-762.
10. Barkovich AJ, Lindan CE. 1994. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am. J. Neuroradiol. 15:703-715.
11. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35:216-220. http://dx.doi .org/10.1016/j.jcv.2005.09.015.
12. Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, Boppana SB. 2006. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J. Pediatr. 148:332-336. http://dx.doi.org/10.1016/j.jpeds.2005.09.003.
13. Kosugi I, Kawasaki H, Arai Y, Tsutsui Y. 2002. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am. J. Pathol. 161:919-928. http://dx .doi.org/10.1016/S0002-9440(10)64252-6.
14. Tsutsui Y, Kawasaki H, Kosugi I. 2002. Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J. Virol. 76:7247-7254. http://dx.doi.org/10.1128/JVI.76.14.7247-7254.2002.
15. Tsutsui Y, Kosugi I, Kawasaki H. 2005. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev. Med. Virol. 15:327-345. http://dx.doi.org/10.1002/rmv.475.
16. Shinmura Y, Kosugi I, Aiba-Masago S, Baba S, Yong LR, Tsutsui Y. 1997. Disordered migration and loss of virus-infected neuronal cells in developing mouse brains infected with murine cytomegalovirus. Acta Neuropathol. 93:551-557. http://dx.doi.org/10.1007/s004010050651.
17. Shinmura Y, Kosugi I, Kaneta M, Tsutsui Y. 1999. Migration of virusinfected neuronal cells in cerebral slice cultures of developing mouse brains after in vitro infection with murine cytomegalovirus. Acta Neuropathol. 98:590-596. http://dx.doi.org/10.1007/s004010051123.
18. Aiba-Masago S, Baba S, Li RY, Shinmura Y, Kosugi I, Arai Y, Nishimura M, Tsutsui Y. 1999. Murine cytomegalovirus immediateearly promoter directs astrocyte-specific expression in transgenic mice. Am. J. Pathol. 154:735-743. http://dx.doi.org/10.1016/S0002-9440(10) 65320-5.
19. Sinclair J, Sissons P. 1996. Latent and persistent infections of monocytes and macrophages. Intervirology 39:293-301.
20. Sinzger C, Jahn G. 1996. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 39:302-319.
21. Khaiboullina SF, Maciejewski JP, Crapnell K, Spallone PA, Dean Stock A, Pari GS, Zanjani ED, Jeor SS. 2004. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br. J. Haematol. 126:410-417. http://dx.doi.org/10.1111/j.1365-2141.2004.05056.x.
22. Meyer-König U, Hufert FT, von Laer DM. 1997. Infection of blood and bone marrow cells with the human cytomegalovirus in vivo. Leuk. Lymphoma 25:445-454.
23. Reeves MB, Sinclair JH. 2010. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91:599-604. http://dx.doi.org/10.1099/vir.0.015602-0.
24. Goodrum F, Reeves M, Sinclair J, High K, Shenk T. 2007. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945. http://dx.doi.org/10 .1182/blood-2007-01-070078.
25. Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES. 2003. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77:7563-7574. http://dx.doi.org/10.1128/JVI.77.13.7563-7574.2003.
26. Goodrum FD, Jordan CT, High K, Shenk T. 2002. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc. Natl. Acad. Sci. U. S. A. 99:16255-16260. http://dx.doi.org/10.1073/pnas.252630899.
27. Cheung AK, Gottlieb DJ, Plachter B, Pepperl-Klindworth S, Avdic S, Cunningham AL, Abendroth A, Slobedman B. 2009. The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 114:4128-4137. http://dx.doi.org/10.1182/blood-2008-12-197111.
28. Rossetto CC, Tarrant-Elorza M, Pari GS. 2013. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells. PLoS Pathog. 9:e1003366. http://dx.doi.org/10.1371/journal.ppat.1003366.
29. Delannoy AS, Hober D, Bouzidi A, Wattre P. 1997. A macrophage-like cell model for testing anti-CMV drugs. Pathol. Biol. (Paris) 45:394-399.
30. Ioudinkova E, Arcangeletti MC, Rynditch A, De Conto F, Motta F, Covan S, Pinardi F, Razin SV, Chezzi C. 2006. Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene 384:120-128. http://dx.doi.org/10.1016/j.gene.2006.07.021.
31. Lee CH, Lee GC, Chan YJ, Chiou CJ, Ahn JH, Hayward GS. 1999. Factors affecting human cytomegalovirus gene expression in human monocyte cell lines. Mol. Cells 9:37-44.
32. Yee LF, Lin PL, Stinski MF. 2007. Ectopic expression of HCMV IE72 and IE86 proteins is sufficient to induce early gene expression but not production of infectious virus in undifferentiated promonocytic THP-1 cells. Virology 363:174-188. http://dx.doi.org/10.1016/j.virol.2007.01.036.
33. Turtinen LW, Seufzer BJ. 1994. Selective permissiveness of TPA differentiated THP-1 myelomonocytic cells for human cytomegalovirus strainsAD169 and Towne. Microb. Pathog. 16:373-378. http://dx.doi.org/10 .1006/mpat.1994.1037.
34. Saffert RT, Kalejta RF. 2007. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J. Virol. 81:9109-9120. http://dx.doi.org/10 .1128/JVI.00827-07.
35. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K. 1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1530-1536.
36. Sanchez V, Dong JJ. 22 May 2010. Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology http://dx.doi.org/10 .1016/j.virol.2010.04.026.
37. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Føgh J. 1984. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab. Invest. 50:147-162.
38. Dósa R, Burián K, Gönczöl E. 2005. Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells. Acta Microbiol. Immunol. Hung. 52:397-406. http://dx.doi.org/10.1556/AMicr.52.2005.3-4.11.
39. Keller MJ, Wu AW, Andrews JI, McGonagill PW, Tibesar EE, Meier JL. 2007. Reversal of human cytomegalovirus major immediate-early enhancer/ promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway. J. Virol. 81:6669-6681. http://dx.doi.org/10.1128/JVI .01524-06.
40. Meier JL. 2001. Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J. Virol. 75:1581-1593. http://dx.doi.org/10.1128 /JVI.75.4.1581-1593.2001.
41. O'Connor CM, Murphy EA. 2012. A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny. J. Virol. 86:9854-9865. http://dx.doi.org/10.1128 /JVI.01278-12.
42. Albright ER, Kalejta RF. 2013. Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations. J. Virol. 87:9802-9812. http://dx.doi.org /10.1128/JVI.01436-13.
43. Kashiwai A, Kawamura N, Kadota C, Tsutsui Y. 1992. Susceptibility of mouse embryo to murine cytomegalovirus infection in early and midgestation stages. Arch. Virol. 127:37-48. http://dx.doi.org/10.1007 /BF01309573.
44. Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O'Dowd JM, Fortunato EA. 2010. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J. Virol. 84:3528-3541. http://dx.doi.org/10.1128/JVI.02161-09.
45. Luo MH, Schwartz PH, Fortunato EA. 6 August 2008. Neonatal neural progenitor cells (NPCs) and their neuronal and glial derivatives are fully permissive for human cytomegalovirus infection. J. Virol. http://dx.doi .org/10.1128/JVI.00943-08.
46. Tebourbi L, Testart J, Cerutti I, Moussu JP, Loeuillet A, Courtot AM. 2002. Failure to infect embryos after virus injection in mouse zygotes. Hum. Reprod. 17:760-764. http://dx.doi.org/10.1093/humrep/17.3.760.
47. Tsutsui Y. 1995. Developmental disorders of the mouse brain induced by murine cytomegalovirus: animal models for congenital cytomegalovirus infection. Pathol. Int. 45:91-102. http://dx.doi.org/10.1111/j.1440-1827 .1995.tb03428.x.
48. Lecointe D, Hery C, Janabi N, Dussaix E, Tardieu M. 1999. Differences in kinetics of human cytomegalovirus cell-free viral release after in vitro infection of human microglial cells, astrocytes and monocytederived macrophages. J. Neurovirol. 5:308-313. http://dx.doi.org/10 .3109/13550289909015817.
49. Cheeran MC, Hu S, Ni HT, Sheng W, Palmquist JM, Peterson PK, Lokensgard JR. 2005. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J. Neurosci. Res. 82:839-850. http://dx.doi.org/10.1002/jnr.20682.
50. Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK. 1999. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J. Hum. Virol. 2:91-101.
51. McCarthy M, Auger D, Whittemore SR. 2000. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J. Hum. Virol. 3:215-228.
52. D'Aiuto L, Di Maio R, Heath B, Raimondi G, Milosevic J, Watson AM, Bamne M, Parks WT, Yang L, Lin B, Miki T, Mich-Basso JD, Arav-Boger R, Sibille E, Sabunciyan S, Yolken R, Nimgaonkar V. 2012. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS One 7:e49700. http: //dx.doi.org/10.1371/journal.pone.0049700.
53. Jault FM, Spector SA, Spector DH. 1994. The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J. Virol. 68:959-973.
54. Poland SD, Costello P, Dekaban GA, Rice GP. 1990. Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J. Infect. Dis. 162:1252-1262. http://dx.doi.org/10.1093/infdis/162.6.1252.
55. Spiller OB, Borysiewicz LK, Morgan BP. 1997. Development of a model for cytomegalovirus infection of oligodendrocytes. J. Gen. Virol. 78(Pt 12):3349-3356.
56. Poland SD, Bambrick LL, Dekaban GA, Rice GP. 1994. The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J. Infect. Dis. 170:1267-1271. http://dx.doi.org /10.1093/infdis/170.5.1267.
57. Cinatl J, Jr, Cinatl J, Vogel JU, Kotchetkov R, Driever PH, Kabickova H, Kornhuber B, Schwabe D, Doerr HW. 1998. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 58:367-372.
58. Cinatl J, Jr, Vogel JU, Cinatl J, Weber B, Rabenau H, Novak M, Kornhuber B, Doerr HW. 1996. Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int. J. Cancer 65:90-96. http://dx.doi.org/10.1002/(SICI)1097-0215(19960103)65:190:: AID-IJC163.0.CO;2-M.
59. Ogura T, Tanaka J, Kamiya S, Sato H, Ogura H, Hatano M. 1986. Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. J. Gen. Virol. 67(Pt 12):2605-2616. http://dx.doi.org/10.1099 /0022-1317-67-12-2605.
60. Tamashiro JC, Hock LJ, Spector DH. 1982. Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169). J. Virol. 42:547-557.
61. McCormick AL, Roback L, Livingston-Rosanoff D, St Clair C. 2010. The human cytomegalovirus UL36 gene controls caspase-dependent and-independent cell death programs activated by infection of monocytes differentiating to macrophages. J. Virol. 84:5108-5123. http://dx.doi.org/10 .1128/JVI.01345-09.
62. Fortunato EA, Dell'Aquila ML, Spector DH. 2000. Specific chromosome 1 breaks induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 97:853-858. http://dx.doi.org/10.1073/pnas.97.2.853.
63. Duan Y, Miao L, Ye H, Yang C, Fu B, Schwartz PH, Rayner S, Fortunato EA, Luo MH. 2012. A faster immunofluorescence assay for tracking infection progress of human cytomegalovirus. Acta Biochim. Biophys. Sin. (Shanghai) 44:597-605. http://dx.doi.org/10.1093/abbs /gms041.
64. O'Dowd JM, Zavala AG, Brown CJ, Mori T, Fortunato EA. 2012. HCMV-infected cells maintain efficient nucleotide excision repair of the viral genome while abrogating repair of the host genome. PLoS Pathog. 8:e1003038. http://dx.doi.org/10.1371/journal.ppat.1003038.
65. Beisser PS, Laurent L, Virelizier JL, Michelson S. 2001. Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J. Virol. 75:5949-5957. http://dx.doi.org/10 .1128/JVI.75.13.5949-5957.2001.
66. Keyes LR, Hargett D, Soland M, Bego MG, Rossetto CC, Almeida-Porada G, St Jeor S. 2012. HCMV protein LUNA is required for viral reactivation from latently infected primary CD14(+) cells. PLoS One 7:e52827. http://dx.doi.org/10.1371/journal.pone.0052827.
67. Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA. 2006. Potential role for p53 in the permissive life cycle of human cytomegalovirus. J. Virol. 80:8390-8401. http://dx.doi.org/10 .1128/JVI.00505-06.
68. Luo MH, Rosenke K, Czornak K, Fortunato EA. 2007. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)-and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 81:1934-1950. http://dx.doi.org/10.1128/JVI .01670-06.
69. Penfold ME, Mocarski ES. 1997. Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins andDNA synthesis. Virology 239:46-61. http://dx.doi.org/10.1006/viro.1997 .8848.
70. Kondo K, Kaneshima H, Mocarski ES. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883. http://dx.doi.org/10.1073/pnas.91.25.11879.
71. Goodrum F, Caviness K, Zagallo P. 2012. Human cytomegalovirus persistence. Cell. Microbiol. 14:644-655. http://dx.doi.org/10.1111/j .1462-5822.2012.01774.x.
72. Slobedman B, Mocarski ES. 1999. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:4806-4812.
73. Dhar SK, Yoshida K, Machida Y, Khaira P, Chaudhuri B, Wohlschlegel JA, Leffak M, Yates J, Dutta A. 2001. Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106: 287-296. http://dx.doi.org/10.1016/S0092-8674(01)00458-5.
74. Verma SC, Choudhuri T, Kaul R, Robertson ES. 2006. Latencyassociated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J. Virol. 80:2243-2256. http://dx.doi .org/10.1128/JVI.80.5.2243-2256.2006.
75. Chaudhuri B, Xu H, Todorov I, Dutta A, Yates JL. 2001. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. U. S. A. 98:10085-10089. http://dx .doi.org/10.1073/pnas.181347998.
76. Schepers A, Ritzi M, Bousset K, Kremmer E, Yates JL, Harwood J, Diffley JF, Hammerschmidt W. 2001. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20:4588-4602. http://dx.doi.org/10.1093/emboj/20 .16.4588.
77. Shinohara H, Fukushi M, Higuchi M, Oie M, Hoshi O, Ushiki T, Hayashi J, Fujii M. 2002. Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1. J. Virol. 76:12917-12924. http://dx.doi.org/10.1128/JVI.76.24.12917-12924.2002.
78. Grundhoff A, Ganem D. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77:2779-2783. http://dx.doi.org/10 .1128/JVI.77.4.2779-2783.2003.
79. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH. 2005. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86:2949-2954. http://dx.doi.org/10.1099/vir.0.81161-0.
80. Murphy JC, Fischle W, Verdin E, Sinclair JH. 2002. Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J. 21: 1112-1120. http://dx.doi.org/10.1093/emboj/21.5.1112.
81. Bloom DC, Giordani NV, Kwiatkowski DL. 2010. Epigenetic regulation of latent HSV-1 gene expression. Biochim. Biophys. Acta 1799:246-256. http://dx.doi.org/10.1016/j.bbagrm.2009.12.001.
82. Knipe DM, Cliffe A. 2008. Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 6:211-221. http://dx.doi .org/10.1038/nrmicro1794.
83. Penkert RR, Kalejta RF. 2013. Human embryonic stem cell lines model experimental human cytomegalovirus latency. mBio 4:e00298-00213. http://dx.doi.org/10.1128/mBio.00298-13.
84. Cui X, Adler SP, Davison AJ, Smith L, Habib el-SE, McVoy MA. 2012. Bacterial artificial chromosome clones of viruses comprising the Towne cytomegalovirus vaccine. J. Biomed. Biotechnol. 2012:428498. http://dx .doi.org/10.1155/2012/428498.
85. Hahn G, Rose D, Wagner M, Rhiel S, McVoy MA. 2003. Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology 307:164-177. http://dx.doi.org/10.1016/S0042-6822(02)00061-2.
86. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk TE. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 100:14976-14981. http://dx.doi.org/10.1073/pnas.2136652100.